Ikarian Capital reported a 4.1% stake in Avenue Therapeutics ATXI · 130,820 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 4.1%
Last report: 6.8% · filed 25/02/14
Shares held: 130,820 sh
Class: Common Stock
Stock: Avenue Therapeutics ATXI
Holder: Ikarian Capital
Event date: 25/12/31
Filed: 26/02/17

4.1% stake · below 5%

Stake: 4.1%
Last report: 6.8%
Since last report: −2.7pp

Avenue Therapeutics trades, last 26 weeks

What else happened in Avenue Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Ikarian Capital's other 5% stake reports

Ikarian Capital
5% stakeCNS Pharmaceuticals
5% stake
CNS Pharmaceuticals
CNSP
9.9% stake
147,290 sh
9.9% stake
Filed 08/14
Ikarian Capital
5% stakeConnect Biopharma Holdings
5% stake
Connect Biopharma Holdings
CNTB
6.9% stake
4,338,534 sh
6.9% stake
Filed 08/14
Ikarian Capital
5% stakeQuince Therapeutics
5% stake
Quince Therapeutics
QNCX
9% stake
91,789 sh
9% stake
Filed 08/14
Ikarian Capital
5% stakeTenax Therapeutics
5% stake
Tenax Therapeutics
TENX
2.9% stake
1,080,700 sh
2.9% stake
Filed 08/14
Ikarian Capital
5% stakeInMed Pharmaceuticals
5% stake
InMed Pharmaceuticals
INM
4.2% stake
137,634 sh
4.2% stake
Filed 08/14